Answer
As a precaution, Tezspire (tezepelumab) should preferably be avoided during pregnancy unless the expected benefit to the mother outweighs any possible risk to the foetus.
Sources for this answer
- Tezspire 210 mg solution for injection in pre-filled syringeAstraZeneca UK Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 4Document updated
Sources checked